
This phase I study was performed to assess the feasibility and possible enhanced zzso activity of the sequential administration of zzso zzso and zzso zzso in patients with solid zzso zzso analysis was performed to investigate the zzso interaction of the two zzso A total of 22 patients were zzso a total of six dose levels were zzso zzso zzso zzso 30, 40 and 50 zzso zzso 2 or day 1) 75 and 85 zzso with supportive care zzso Both zzso and zzso zzso were zzso preventing dose escalation above zzso 40 zzso 75 zzso Four partial responses were zzso three in patients with breast cancer, one in a patient with zzso cell zzso zzso data did not give an explanation for the significant toxicity as they revealed no interaction of D and zzso zzso zzso and zzso zzso zzso seemed to be independent of the administration of D and the moment of D administration appeared not to influence zzso zzso The sequential administration of zzso and D results in significant toxicity without any evidence of a clinical zzso 

